Form 4: Biohaven Director Acquires Stock Options
SEC Form 4 Filing
A Biohaven director, Robert J. Hugin, acquired 31,716 stock options at an exercise price of $22.62 on May 5, 2025.
Summary
- On May 5, 2025, Robert J. Hugin, a director of Biohaven Ltd., acquired 31,716 stock options.
- The exercise price for these options is $22.62.
- The options vest on the earlier of May 5, 2026, or the date of the 2026 Annual Meeting of Shareholders, contingent upon continuous service with Biohaven.
- Following the transaction, Hugin directly owns 31,716 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting a standard stock option grant to a company director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This is a standard SEC Form 4 filing, indicating a change in beneficial ownership of securities by a company insider. It's a routine part of corporate governance and transparency.
Stakeholder Impact
- The acquisition of stock options by a director could align the director's interests more closely with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/05/2025 | Date of transaction: Director acquired stock options. |
| 05/05/2025 | Date of transaction: Director acquired stock options. |
| 05/05/2026 | Earliest possible vesting date for the stock options. |
| 05/07/2025 | Date of signature for the Form 4 filing. |
| 05/05/2035 | Expiration date of the stock options. |
Keywords
stock options, Biohaven, director, acquisition, BHVN, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.